Literature DB >> 2839552

Direct relationship between mononuclear leukocyte and lung beta-adrenergic receptors and apparent reciprocal regulation of extravascular, but not intravascular, alpha- and beta-adrenergic receptors by the sympathochromaffin system in humans.

S B Liggett1, J C Marker, S D Shah, C L Roper, P E Cryer.   

Abstract

To examine putative relationships between adrenergic receptors on accessible circulating cells and relatively inaccessible extravascular catecholamine target tissues, we measured mononuclear leukocyte (MNL) and lung beta-adrenergic receptors and platelet and lung alpha-adrenergic receptors in tissues obtained from 15 patients undergoing pulmonary resection. Plasma catecholamine concentrations were measured concurrently to explore potential regulatory relationships between the activity of the sympathochromaffin system and both intravascular and extravascular adrenergic receptors. MNL and lung membrane beta-adrenergic receptor densities were correlated highly (r = 0.845, P less than 0.001). Platelet alpha 2-adrenergic receptor and lung alpha 1-adrenergic receptor densities were not. Lung alpha 1-adrenergic receptor densities were positively related to plasma norepinephrine (r = 0.840, P less than 0.01) and epinephrine (r = 0.860, P less than 0.01) concentrations; in contrast, lung beta-adrenergic receptor densities were not positively related to plasma catecholamine concentrations (they tended to be inversely related to plasma norepinephrine and epinephrine [r = -0.698, P less than 0.05] levels). This apparent reciprocal regulation of alpha- and beta-adrenergic receptors by the sympathochromaffin system was only demonstrable with adrenergic receptor measurements in the extravascular catecholamine target tissue. Neither MNL beta-adrenergic receptor nor platelet alpha-adrenergic receptor densities were correlated with plasma catecholamine levels. Thus, although measurements of beta-adrenergic receptors on circulating mononuclear leukocytes can be used as indices of extravascular target tissue beta-adrenergic receptor densities (at least in lung and heart), it would appear that extravascular tissues should be used to study adrenergic receptor regulation by endogenous catecholamines in humans. These data provide further support for the concept of up regulation, as well as down regulation, of some adrenergic receptor populations during short-term activation of the sympathochromaffin system in humans.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839552      PMCID: PMC303475          DOI: 10.1172/JCI113600

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  54 in total

1.  Beta receptors in peripheral mononuclear cells increase acutely during exercise.

Authors:  K D Burman; E W Ferguson; Y Y Djuh; L Wartofsky; K Latham
Journal:  Acta Endocrinol (Copenh)       Date:  1985-08

2.  Agonist-mediated regulation of alpha 1- and beta 2-adrenergic receptors in cloned MDCK cells.

Authors:  K E Meier; D M Sperling; P A Insel
Journal:  Am J Physiol       Date:  1985-07

3.  Inappropriate correction for radioactive decay in fully iodinated adrenergic radioligands.

Authors:  V M Doyle; F R Bühler; E Bürgisser
Journal:  Eur J Pharmacol       Date:  1984-04-06       Impact factor: 4.432

4.  Alpha- and beta-adrenergic receptor activity in circulating blood cells of patients with phaeochromocytoma: effects of adrenalectomy.

Authors:  D Ratge; H Wisser
Journal:  Acta Endocrinol (Copenh)       Date:  1986-01

5.  Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine.

Authors:  M A Pfeifer; K Ward; T Malpass; J Stratton; J Halter; M Evans; H Beiter; L A Harker; D Porte
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

6.  Use of superoxide dismutase and catalase to protect catecholamines from oxidation in tissue culture studies.

Authors:  L C Mahan; P A Insel
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

7.  Beta adrenergic receptors in lymphocyte subpopulations.

Authors:  N H Bishopric; H J Cohen; R J Lefkowitz
Journal:  J Allergy Clin Immunol       Date:  1980-01       Impact factor: 10.793

8.  Acute reduction in human platelet alpha 2-adrenoreceptor affinity for agonist by endogenous and exogenous catecholamines.

Authors:  A S Hollister; G A FitzGerald; J H Nadeau; D Robertson
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

9.  Biphasic adrenergic modulation of beta-adrenergic receptors in man. Agonist-induced early increment and late decrement in beta-adrenergic receptor number.

Authors:  J F Tohmeh; P E Cryer
Journal:  J Clin Invest       Date:  1980-04       Impact factor: 14.808

10.  [125I]iodopindolol: a new beta adrenergic receptor probe.

Authors:  E G Ezrailson; A J Garber; P J Munson; T L Swartz; L Birnbaumer; M L Entman
Journal:  J Cyclic Nucleotide Res       Date:  1981
View more
  9 in total

1.  Up-regulation of beta-adrenoceptors on circulating mononuclear cells after reduction of central sympathetic outflow by clonidine in normal subjects.

Authors:  Y Zoukos; T Thomaides; D V Pavitt; J P Leonard; M L Cuzner; C J Mathias
Journal:  Clin Auton Res       Date:  1992-06       Impact factor: 4.435

2.  Effects of insulin on human beta-adrenoceptors.

Authors:  G Sager
Journal:  Br J Clin Pharmacol       Date:  1990       Impact factor: 4.335

3.  MicroRNA let-7 establishes expression of beta2-adrenergic receptors and dynamically down-regulates agonist-promoted down-regulation.

Authors:  Wayne C H Wang; Aster H Juan; Alfredo Panebra; Stephen B Liggett
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-29       Impact factor: 11.205

Review 4.  Beta-adrenoceptor responsiveness in hypertension: effects of dietary NaCl intake.

Authors:  R D Feldman
Journal:  Br J Clin Pharmacol       Date:  1990       Impact factor: 4.335

5.  Increased fat and skeletal muscle beta-adrenergic receptors but unaltered metabolic and hemodynamic sensitivity to epinephrine in vivo in experimental human thyrotoxicosis.

Authors:  S B Liggett; S D Shah; P E Cryer
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

6.  Altered adrenoceptor responsiveness during adrenaline infusion but not during mental stress: differences between receptor subtypes and tissues.

Authors:  P T Larsson; A Martinsson; G Olsson; P Hjemdahl
Journal:  Br J Clin Pharmacol       Date:  1989-12       Impact factor: 4.335

Review 7.  Beta 2 adrenergic receptors in asthma: a current perspective.

Authors:  T R Bai
Journal:  Lung       Date:  1992       Impact factor: 2.584

8.  Stimulation of lung epithelial liquid clearance by endogenous release of catecholamines in septic shock in anesthetized rats.

Authors:  J F Pittet; J P Wiener-Kronish; M C McElroy; H G Folkesson; M A Matthay
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

Review 9.  Clinical pharmacokinetics of beta-agonists.

Authors:  D J Morgan
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.